drugset / Trial / NCT02846181

A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405

NCT02846181 ↗

Phase 1 Completed 6 enrolled Sanwa Kagaku Kenkyusho Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

The primary objectives of the study are: * To assess the mass balance recovery after a single PO dose of \[14C\]-SK-1405 * To provide plasma, urine and faecal samples for metabolite profiling and structural identification

Timeline

Start
2016-07
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject SK-1405 Unknown — Oral

Indications

No indication recorded.